Assignee
ESCEND PHARMACEUTICALS INC
US·0 granted patents·3 pending applications·0 citations·filing 2024–2024
Top patents by PatentIndex Score
3 records- 0161US2024307372A1Compositions and methods to improve benefit of suboptimally administered therapeuctics for the treatment of benign and neoplastic diseases, infections, inflammatory, metabolic and immunologial diseasesESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0261US2024307373A1Methods of use and compositions of bisbenzylisoquinolines for the treatment of malignanciesESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0361US2024342161A1Bisbenzylisoquinolines as conditioning agents for immune therapyESCEND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ESCEND PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →